Incidental hepatic steatosis in radiology reports: a survey of emergency department clinicians' perspectives and current practice.
Cross-Sectional Studies
Emergency Service, Hospital
Fatty Liver
/ diagnostic imaging
Humans
Incidental Findings
Interdisciplinary Communication
Practice Patterns, Physicians'
/ statistics & numerical data
Prospective Studies
Radiography, Abdominal
Surveys and Questionnaires
Tomography, X-Ray Computed
computed tomography
emergency medicine
fatty liver
incidental findings
nonalcoholic fatty liver disease
Journal
Journal of medical imaging and radiation oncology
ISSN: 1754-9485
Titre abrégé: J Med Imaging Radiat Oncol
Pays: Australia
ID NLM: 101469340
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
25
03
2019
revised:
02
06
2019
accepted:
14
07
2019
pubmed:
7
8
2019
medline:
11
3
2020
entrez:
7
8
2019
Statut:
ppublish
Résumé
Hepatic steatosis is a relatively common incidental finding on computed tomography (CT) studies performed for patients in the emergency department (ED). The aim of our survey was to explore the preferences and perspectives of emergency physicians regarding reporting of incidental findings with a focus on hepatic steatosis. A prospective web-based questionnaire was conducted and distributed electronically to emergency clinicians with anonymous collection of responses. A total of 236 responses were received. The true response rate could not be determined due to different methods of electronic distribution. However, there was an estimated representation of 8.3% for ED physicians and 2.5% for trainees. The median time spent on the survey was less than 3 minutes. Seventy-seven per cent answered yes to giving an incidental finding more significance if mentioned in the conclusion section. More than half of respondents (60.2%) reported that they would like hepatic steatosis to be mentioned in a CT report while 30% reported that it was irrelevant in the emergency setting and 10% reported that they did not want it mentioned in the report. The majority (83.1%) reported that they would include this finding in the discharge summary for GP follow-up and less than half (44.1%) would mention it to patients. Our survey highlights the importance of clear communication between radiologists and ED physicians when incidental findings are encountered. Radiologists play an important role in alerting ED physicians and clinicians who have access to patients' radiology reports to the presence of incidental findings including hepatic steatosis.
Identifiants
pubmed: 31385415
doi: 10.1111/1754-9485.12938
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
573-579Informations de copyright
© 2019 The Royal Australian and New Zealand College of Radiologists.
Références
Wells MM, Li Z, Addeman B et al. Computed tomography measurement of hepatic steatosis: prevalence of hepatic steatosis in a Canadian Population. Canad J Gastroenterol Hepatol 2016; 2016: 4930987.
Chalasani N, Younossi Z. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018; 67: 328-57.
Dam-Larsen S, Franzmann M, Andersen IB et al. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 2004; 53: 750-5.
Adams LA, Lymp JF, St Sauver J et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-21.
Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore, MD) 2016; 64: 73-84.
Kanwal F, Kramer JR, Mapakshi S et al. Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease. Gastroenterology 2018; 155: 1828-37.e2.
Dulai PS, Singh S, Patel J et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology (Baltimore, MD) 2017; 65: 1557-65.
Mellinger JL, Pencina KM, Massaro JM et al. Hepatic steatosis and cardiovascular disease outcomes: an analysis of the Framingham Heart Study. J Hepatol 2015; 63: 470-6.
Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011; 43: 617-49.
Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. New Engl J Med 2010; 363: 1341-50.
Andrawes P, Picon AI, Shariff MA et al. CT scan incidental findings in trauma patients: does it impact hospital length of stay? Trauma Surg Acute Care Open 2017; 2: e000101-e.
Hoppe H, Studer R, Kessler TM, Vock P, Studer UE, Thoeny HC. Alternate or additional findings to stone disease on unenhanced computerized tomography for acute flank pain can impact management. J Urol 2006; 175: 1725-30.
Thompson RJ, Wojcik SM, Grant WD, Ko PY. Incidental findings on CT scans in the emergency department. Emerg Med Int 2011; 2011: 624847.
Wieland AC, Quallick M, Truesdale A, Mettler P, Bambha KM. Identifying practice gaps to optimize medical care for patients with nonalcoholic fatty liver disease. Digest Dis Sci 2013; 58: 2809-16.
Bergqvist CJ, Skoien R, Horsfall L, Clouston AD, Jonsson JR, Powell EE. Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists. Int Med J 2013; 43: 247-53.
Patel PJ, Banh X, Horsfall LU, et al. Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis. Int Med J 2018; 48: 144-51.
Gore RM, Pickhardt PJ, Mortele KJ et al. Management of incidental liver lesions on CT: a White Paper of the ACR Incidental Findings Committee. J Am College Radiol 2017; 14: 1429-37.
Kutaiba N, Richmond D, Morey M et al. Incidental hepatic steatosis on unenhanced computed tomography performed for suspected renal colic: Gaps in reporting and documentation. J Med Imaging Radiat Oncol 2019; 63: 431-8.
Judkins S. ACEM President response: mandatory misrepresentation. Emerg Med Australasia 2018; 30: 117-8.
Younossi Z, Anstee QM, Marietti M et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2017; 15: 11-20.
Wright AP, Desai AP, Bajpai S, King LY, Sahani DV, Corey KE. Gaps in recognition and evaluation of incidentally identified hepatic steatosis. Digest Dis Sci 2015; 60: 333-8.
Tang A, Cloutier G, Szeverenyi NM, Sirlin CB. Ultrasound elastography and MR elastography for assessing liver fibrosis: Part 2, diagnostic performance, confounders, and future directions. AJR 2015; 205: 33-40.
Murray TE, Ma SD, Doyle F, Lee MJ. Radiology reporting of obesity: a survey of patient and clinician attitudes. Clin Radiol 2018; 73: 506.e9-506.e15.
Park SH, Kim PN, Kim KW et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 2006; 239: 105-12.
Iser D, Ryan M. Fatty liver disease - a practical guide for GPs. Australian Fam Phys 2013; 42: 444-7.
Mendez-Sanchez N, Chavez-Tapia NC, Almeda-Valdes P, Uribe M. The management of incidental fatty liver found on imaging. What do we need to do? Am J Gastroenterol 2018; 113: 1274-6.
Mai Q, Aboagye-Sarfo P, Sanfilippo FM, Preen DB, Fatovich DM. Predicting the number of emergency department presentations in Western Australia: a population-based time series analysis. Emerg Med Australasia 2015; 27: 16-21.
Grieve FM, Plumb AA, Khan SH. Radiology reporting: a general practitioner's perspective. Brit J Radiol 2010; 83: 17-22.
Zafar HM, Bugos EK, Langlotz CP, Frasso R. “Chasing a Ghost”: Factors that influence primary care physicians to follow up on incidental imaging findings. Radiology 2016; 281: 567-73.
Ma X, Holalkere N-S, Kambadakone et al. Imaging-based quantification of hepatic fat: methods and clinical applications. Radiographics 2009; 29: 1253-77.